Catalent's IPO

Catalent raised a round of funding on July 31, 2014. Investors include Public.

Catalent (NYSE:CTLT), aka Catalent Pharma Solutions, is a global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products.…

Articles about Catalent's IPO: